We explore the evidence that informs ambulatory care pharmacy practice. Check out our website & podcasts, & consider submitting a commentary!
Episodes
Aug 8, 2025
Aug 8, 2025
17 min
Heart failure with preserved ejection fraction (HFpEF) poses a significant challenge because of its heterogeneous nature and the scarcity of therapies that meaningfully alter its course. The SUMMIT study evaluated the impact of tirzepatide on symptoms and mortality in people with HFpEF and obesity.
Guests: Jennifer N. Clements, Pharm.D., FCCP, FADCES, BCPS, BCACP, BC-ADM, CDCES and Dawn C. Fuke, Pharm.D., BCPS, BCACP
Music by Good Talk
No comments yet. Be the first to say something!